Biotech

To keep pace with large-scale manufacturing needs, Cambridge Major will build a new 120,000-square-foot plant next to its Germantown headquarters. The facility, which is scheduled for completion in August of 2009, will contain several manufacturing suites that are capable of making multi-ton quantities of the...

The Wisconsin Alumni Research Foundation has entered into licensing agreements involving new flu technology and human embryonic stem cell technology. WARF has licensed vaccine technology to FluGen, a local start-up founded by UW-Madison professor Yoshihiro Kawaoka, and it has licensed stem cell technology to the...

GWC Technologies of Madison has chosen Biotron Healthcare of Mumbai, India as its exclusive distributor of products in India. The Madison company, which exports products to more than a dozen nations, manufactures label-free arrays used for life-science applications such as proteomics analysis, drug discovery research,...

The weak dollar has played a role in the sluggish U.S. economy, but it also has made American life-science companies a real bargain for foreign investors, according to columnist Michael Rosen. In this edtion of Yer Biotech Blues, Rosen explains why American biotechs rarely have...

Platypus Technologies of Madison has announced the appointment of Eric Apfelbach, president and CEO of the Madison-based Virent Energy Systems, to its board of directors. Apfelbach, who also founded another Madison company, Alfalight, was appointed for his combination of scientific and business skills and...

Even though Madison's Third Wave Technologies has reported its 10th consecutive quarter of clinical revenue growth, the company also reported a net loss of $7.6 million, or $0.11 per share, during the first quarter of 2008. The company could soon close the gap because it...

The Madison-based Promega Corp. has developed an automated system to reduce the time it takes to analyze DNA samples found at crime scenes. The company's patent-pending extraction system promises to reduce from days to hours the time it takes to process DNA gathered in sexual...

The submission of two pre-market applications to the Food and Drug Administration for human papillomavirus, or HPV tests, is based on the strength of clinical trial data, according to Third Wave Technologies. The Madison biotechnology company expects to be on the market with the HPV...